SEC Form 4 · accession 0001209191-16-123339
ImmunityBio, Inc. · IBRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Steve Gorlin
Director
Period of report
May 23, 2016
Accepted (ET)
May 25, 2016 · 6:52 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001326110
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 23, 2016 | M | 324,012 | $0.2161 | A | 729,725 | D | |
| Common Stock | holding | — | — | — | 221,720 | I | By spouse |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) | $0.2161 | May 23, 2016 | M | 324,012 | D | Mar 17, 2014 | Mar 17, 2024 | Common Stock | 324,012 | 0 | D |